A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Clinical trial NCT06747585 · RECRUITING

Trial details

NCT number: NCT06747585
Sponsor: Alentis Therapeutics AG
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Squamous Non-small-cell Lung Cancer Head and Neck Squamous Cell Carcinoma Cervical Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma

Start date: 2024-12-16
Primary completion: 2028-02-15
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.